Khramtsov Yuri V, Ulasov Alexey V, Rosenkranz Andrey A, Slastnikova Tatiana A, Lupanova Tatiana N, Georgiev Georgii P, Sobolev Alexander S
Laboratory of Molecular Genetics of Intracellular Transport, Institute of Gene Biology of Russian Academy of Sciences, 34/5 Vavilov St., 119334 Moscow, Russia.
Faculty of Biology, Lomonosov Moscow State University, 1-12 Leninskie Gory St., 119234 Moscow, Russia.
Pharmaceutics. 2023 Jan 18;15(2):324. doi: 10.3390/pharmaceutics15020324.
To compare the effectiveness of various bioactive agents reversibly acting within a cell on a target intracellular macromolecule, it is necessary to assess effective cytoplasmic concentrations of the delivered bioactive agents. In this work, based on a simple equilibrium model and the cellular thermal shift assay (CETSA), an approach is proposed to assess effective concentrations of both a delivered bioactive agent and a target protein. This approach was tested by evaluating the average concentrations of nuclear factor erythroid 2-related factor 2 (Nrf2) and Kelch-like ECH-associated-protein 1 (Keap1) proteins in the cytoplasm for five different cell lines (Hepa1, MEF, RAW264.7, 3LL, and AML12) and comparing the results with known literature data. The proposed approach makes it possible to analyze both binary interactions and ternary competition systems; thus, it can have a wide application for the analysis of protein-protein or molecule-protein interactions in the cell. The concentrations of Nrf2 and Keap1 in the cell can be useful not only in analyzing the conditions for the activation of the Nrf2 system, but also for comparing the effectiveness of various drug delivery systems, where the delivered molecule is able to interact with Keap1.
为了比较各种在细胞内可逆作用于目标细胞内大分子的生物活性剂的有效性,有必要评估所递送生物活性剂的有效细胞质浓度。在这项工作中,基于一个简单的平衡模型和细胞热位移分析(CETSA),提出了一种评估所递送生物活性剂和目标蛋白有效浓度的方法。通过评估五种不同细胞系(Hepa1、MEF、RAW264.7、3LL和AML12)细胞质中核因子红细胞2相关因子2(Nrf2)和类 Kelch 样 ECH 相关蛋白1(Keap1)的平均浓度,并将结果与已知文献数据进行比较,对该方法进行了测试。所提出的方法能够分析二元相互作用和三元竞争系统;因此,它在分析细胞中的蛋白质-蛋白质或分子-蛋白质相互作用方面具有广泛的应用。细胞中Nrf2和Keap1的浓度不仅有助于分析Nrf2系统的激活条件,还可用于比较各种药物递送系统的有效性,其中所递送的分子能够与Keap1相互作用。